Verici Dx PLC

VRCI

Company Profile

  • Business description

    Verici Dx PLC is an immuno-diagnostics development company. The company is focused on the development of prognostic and diagnostic tests for kidney transplant patients. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; Tuteva, a post-transplant diagnostic focused upon acute cellular rejection, including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels; and Protega will utilize RNA gene signatures to more accurately risk stratify outcome from fibrosis in a transplant patient. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

  • Contact

    19 Stanwell Road
    Avon House
    Penarth
    CardiffCF64 2EZ
    GBR

    T: +44 2920710570

    https://www.vericidx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    15

Stocks News & Analysis

stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.
stocks

After earnings, is Tesla stock a buy, a sell, or fairly valued?

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,221.1014.400.16%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE26,245.1937.50-0.14%
NASDAQ23,581.14377.33-1.57%
Nikkei 22551,946.83621.221.21%
NZX 50 Index13,549.0589.760.67%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,923.6010.400.12%
SSE Composite Index3,972.7114.19-0.36%

Market Movers